PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2887
https://www.valueinhealthjournal.com/article/S1098-3015(18)36262-4/fulltext
Title :
PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36262-4&doi=10.1016/j.jval.2018.09.2887
First page :
Section Title :
Open access? :
No
Section Order :
1078